The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The wellness world is eager for RFK Jr.'s promised move on peptides : NPR Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide